(Q34174215)

31 July 2017

1 reference

title

Genetic counselling and genetic screening for Alzheimer's disease and other dementias (English)

1 reference

31 July 2017

0 references

Sadovnick AD

1

1 reference

31 July 2017

publication date

1 February 2001

1 reference

Canadian Journal of Neurological Sciences

31 July 2017

published in

1 reference

31 July 2017

volume

28 Suppl 1

1 reference

31 July 2017

page(s)

S52-5

1 reference

Familial risks for Alzheimer disease from a population-based series

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

Apolipoprotein E polymorphism and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

The molecular and genetic basis of AD: the end of the beginning: the 2000 Wartenberg lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

New insights into genetic aspects of Alzheimer's disease. Does genetic information make a difference in clinical practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

Statement on Use of Apolipoprotein E Testing for Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

The genetic attributable risk of breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

7 January 2021

Apolipoprotein E genotyping in the diagnosis of alzheimer's disease: A cautionary view

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

7 January 2021

Meeting report: the Fifth International Conference on Alzheimer's Disease and Related Disorders

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

7 January 2021

Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

7 January 2021

Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12-21.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

7 January 2021

Biochemical assay for AD7C-NTP in urine as an Alzheimer's disease marker.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001207

7 January 2021

10.1017/S0317167100001207

Identifiers

DOI

1 reference

31 July 2017

1 reference